Impact Biomedical Inc.
IBO· NYSE
Released Aug 14, 2025, during market hours
10-Q filed Aug 14, 2025, 45 days after period end · 0001641172-25-023809
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $7.00K | — | — | $50.00K |
| Net Income | -$14.35M | -$889.00K | -$1.12M | -$799.00K |
| EPS Diluted | -$1.18 |
Impact Biomedical Inc. · CIK 1834105 · Engraved from SEC EDGAR
| -$0.09 |
| -$0.02 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.